Cita APA

López-Miranda, E., Perez-Garcia, J. M., Brain, E., Ravnik, M., Escriva de Romaní Muñoz, S. I., Cortés Castan, J., & Di Cosimo, S. (2020). Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial.

Citación estilo Chicago

López-Miranda, Elena, Jose Manuel Perez-Garcia, Etienne Brain, Maja Ravnik, Santiago Ignacio Escriva de Romaní Muñoz, Javier Cortés Castan, y Serena Di Cosimo. Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial. 2020.

Cita MLA

López-Miranda, Elena, et al. Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial. 2020.